Skip to content

Author

Anand Gupta

We have 3 of 23 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical Outcomes of Santreva™-ATK Endovascular Revascularization Catheter in Patients with Claudication and Critical Limb-Threatening Ischemia.

BACKGROUND Patients with femoropopliteal (FP) chronic total occlusions (CTOs) presenting with intermittent claudication (IC) and chronic limb threatening ischemia (CLTI) differ in disease severity and lesion complexity. We performed a subgroup analysis of the prospective, multicenter RESTOR-1 trial to evaluate the safe...

Shalini Sharma, Anand Gupta, Peter A. Soukas et al. · 0 citations
Review Aug 2026

The Cancer-Associated Lipid Paradox: Implications for Cardiovascular Risk and Lipid Management.

This review synthesizes mechanistic, angiographic, and clinical evidence underpinning the lipid paradox in cancer, evaluates contemporary lipid-lowering strategies, and proposes a precision cardio-oncology framework that moves beyond LDL-centric paradigms toward a dynamic longitudinal risk-based prevention.

Nicole Prescott, Victoria Eichten, Vishal Ahuja et al. · 0 citations
Aug 2026

Early And Long-term Outcomes After DOAC Initiation In Hospitalized Patients With Newly Diagnosed Atrial Fibrillation.

Overall, DOAC initiation at discharge in patients with newly diagnosed AF identified between 3 days before hospital admission and hospital discharge was associated with lower early and long-term ischemic risk, with lower rates of both MACE and NACE observed at 30 days and 3 years, underscoring the need for individualiz...

Matthew Cervantes, Tariq Jamal Siddiqi, Anand Gupta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.